Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1986 2
1988 4
1989 3
1990 4
1991 2
1992 5
1993 3
1994 2
1996 2
1999 1
2000 2
2017 1
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.
Berlin J, Ramanathan RK, Strickler JH, Subramaniam DS, Marshall J, Kang YK, Hetman R, Dudley MW, Zeng J, Nickner C, Xiong H, Komarnitsky P, Shepherd SP, Hurwitz H, Lenz HJ. Berlin J, et al. Among authors: dudley mw. Br J Cancer. 2018 Apr;118(7):938-946. doi: 10.1038/s41416-018-0003-3. Epub 2018 Mar 12. Br J Cancer. 2018. PMID: 29527010 Free PMC article. Clinical Trial.
MDL 27,531 selectively reverses strychnine-induced seizures in mice.
Kehne JH, Kane JM, Miller FP, Ketteler HJ, Braun DL, Senyah Y, Chaney SF, Abdallah A, Dudley MW, Ogden AM, et al. Kehne JH, et al. Among authors: dudley mw. Br J Pharmacol. 1992 Aug;106(4):910-6. doi: 10.1111/j.1476-5381.1992.tb14434.x. Br J Pharmacol. 1992. PMID: 1327393 Free PMC article.
Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study.
Czito BG, Deming DA, Jameson GS, Mulcahy MF, Vaghefi H, Dudley MW, Holen KD, DeLuca A, Mittapalli RK, Munasinghe W, He L, Zalcberg JR, Ngan SY, Komarnitsky P, Michael M. Czito BG, et al. Among authors: dudley mw. Lancet Gastroenterol Hepatol. 2017 Jun;2(6):418-426. doi: 10.1016/S2468-1253(17)30012-2. Epub 2017 Mar 27. Lancet Gastroenterol Hepatol. 2017. PMID: 28497757 Clinical Trial.
33 results